Screener
Neuropace, Inc. NPCE Return on invested capital
Return on invested capital at other companies
Other financials
Where this comes from
Calculated from Neuropace, Inc.’s reported figures.
Based on trailing twelve months.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s return on invested capital?
- Neuropace, Inc. (NPCE) reported return on invested capital of -22% in Q2 2026.
- How has Neuropace, Inc.'s return on invested capital changed year-over-year?
- Neuropace, Inc.'s return on invested capital increased by 28.2% year-over-year, from -30.6% to -22%.
- What is the long-term trend for Neuropace, Inc.'s return on invested capital?
- Over 3 years (2022 to 2025), Neuropace, Inc.'s return on invested capital has grown at a -12.6% compound annual growth rate (CAGR), from -39% to -26.1%.
- What does return on invested capital mean?
- Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.
Ask your AI about Neuropace, Inc.'s return on invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude